{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T06:46:12Z","timestamp":1793774772344,"version":"4.6.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1136\/ijgc-2021-003327","type":"journal-article","created":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T12:42:11Z","timestamp":1648644131000},"page":"716-723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7342-462X","authenticated-orcid":false,"given":"Alexandra","family":"Wagner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sophie","family":"Skof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rolf","family":"Richter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Henrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"von Weizs\u00e4cker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Peter","family":"Siedentopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslav","family":"Chekerov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Rohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ijgc-2021-003327_bb0010","author":"World health Organization","year":"2018","journal-title":"Who director-general calls for all countries to take action to help end the suffering caused by cervical cancer"},{"key":"10.1136\/ijgc-2021-003327_bb0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ygyno.2021.02.033","article-title":"Gynecologic oncology on the global health agenda: a wake-up call","volume":"161","author":"Ullrich","year":"2021","journal-title":"Gynecol Oncol"},{"key":"10.1136\/ijgc-2021-003327_bb0020","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/s41416-020-0920-9","article-title":"Cervical screening: ESGO-EFC position paper of the European Society of Gynaecologic oncology (ESGO) and the European Federation of colposcopy (EFC)","volume":"123","author":"Kyrgiou","year":"2020","journal-title":"Br J Cancer"},{"key":"10.1136\/ijgc-2021-003327_bb0025","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1093\/jnci\/djq356","article-title":"Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence","volume":"102","author":"Kj\u00e6r","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2021-003327_bb0030","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1093\/jnci\/87.11.796","article-title":"Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group","volume":"87","author":"Bosch","year":"1995","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2021-003327_bb0035","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","article-title":"Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis","volume":"8","author":"Arbyn","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1136\/ijgc-2021-003327_bb0040","author":"World health Organization","year":"2021","journal-title":"Who guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention second edition"},{"key":"10.1136\/ijgc-2021-003327_bb0045","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1136\/sextrans-2016-053070","article-title":"A systematic review and meta-analysis of studies evaluating the performance of point-of-care tests for human papillomavirus screening","volume":"93","author":"Kelly","year":"2017","journal-title":"Sex Transm Infect"},{"key":"10.1136\/ijgc-2021-003327_bb0050","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/cam4.1334","article-title":"Knowledge about cervical cancer and barriers toward cervical cancer screening among HIV-positive women attending public health centers in Addis Ababa City, Ethiopia","volume":"7","author":"Shiferaw","year":"2018","journal-title":"Cancer Med"},{"key":"10.1136\/ijgc-2021-003327_bb0055","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1471-2407-10-310","article-title":"Self-reported history of pap-smear in HIV-positive women in northern Italy: a cross-sectional study","volume":"10","author":"Dal Maso","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1136\/ijgc-2021-003327_bb0060","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/ijc.32260","article-title":"Cervical cancer risk in women living with HIV across four continents: a multicohort study","volume":"146","author":"Rohner","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2021-003327_bb0065","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/cid\/cix135","article-title":"Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer","volume":"64","author":"Clifford","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1136\/ijgc-2021-003327_bb0070","author":"Robert Koch Institut GdeKiDeVG","year":"2020","journal-title":"HIV in Deutschland - Eckdaten der Sch\u00e4tzung Stand: Ende 2020"},{"key":"10.1136\/ijgc-2021-003327_bb0075","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1055\/s-0034-1383216","volume":"74","author":"Quaas","year":"2014","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1136\/ijgc-2021-003327_bb0080","article-title":"Remarks on the \"Comments on the Publication of Munich Nomenclature III by the Cytology Coordination Conference\" by A. Schneider and P. Hillemanns (Geburtsh Frauenheilk 2014; 74: 242-243)","volume":"74","author":"Griesser","year":"2014","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"10.1136\/ijgc-2021-003327_bb0085","author":"Deutsche AIDS-Gesellschaft e.V. \u00d6AG","year":"2020","journal-title":"Deutsch-\u00d6sterreichische Leitlinien zur antiretroviralen Therapie der HIV-Infektion [Guideline]"},{"key":"10.1136\/ijgc-2021-003327_bb0090","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1128\/JCM.02227-07","article-title":"Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers","volume":"46","author":"Schmitt","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1136\/ijgc-2021-003327_bb0095","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ijc.24010","article-title":"Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older","volume":"124","author":"Meijer","year":"2009","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2021-003327_bb0100","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jcv.2015.09.014","article-title":"VALGENT: a protocol for clinical validation of human papillomavirus assays","volume":"76 Suppl 1","author":"Arbyn","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1136\/ijgc-2021-003327_bb0105","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1136\/ijgc-2021-003327_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/1750-9378-7-38","article-title":"Potential impact of a nine-valent vaccine in human papillomavirus related cervical disease","volume":"7","author":"Serrano","year":"2012","journal-title":"Infect Agent Cancer"},{"key":"10.1136\/ijgc-2021-003327_bb0115","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/01.aids.0000253361.63578.14","article-title":"Human papillomavirus types among women infected with HIV: a meta-analysis","volume":"20","author":"Clifford","year":"2006","journal-title":"AIDS"},{"key":"10.1136\/ijgc-2021-003327_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003528","article-title":"Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: a cohort study","volume":"18","author":"Kelly","year":"2021","journal-title":"PLoS Med"},{"key":"10.1136\/ijgc-2021-003327_bb0125","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/QAI.0000000000001113","article-title":"Effect of HIV infection on human papillomavirus types causing invasive cervical cancer in Africa","volume":"73","author":"Clifford","year":"2016","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1136\/ijgc-2021-003327_bb0130","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1473-3099(07)70158-5","article-title":"Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis","volume":"7","author":"de Sanjos\u00e9","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1136\/ijgc-2021-003327_bb0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1093\/jnci\/djn044","article-title":"Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections","volume":"100","author":"Rodr\u00edguez","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1136\/ijgc-2021-003327_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137434","article-title":"Prevalence of anal human papillomavirus infection and risk factors among HIV-positive patients in Tokyo, Japan","volume":"10","author":"Nagata","year":"2015","journal-title":"PLoS One"},{"key":"10.1136\/ijgc-2021-003327_bb0145","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/ijc.31537","article-title":"A case-control study of HIV infection and cancer in the era of antiretroviral therapy in Rwanda","volume":"143","author":"Mpunga","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2021-003327_bb0150","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/QAD.0000000000002717","article-title":"Risk of smoking-related cancers among women and men living with and without HIV","volume":"35","author":"Hessol","year":"2021","journal-title":"AIDS"},{"key":"10.1136\/ijgc-2021-003327_bb0155","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/infdis\/jiaa135","article-title":"HIV modifies the effect of tobacco smoking on oral human papillomavirus infection","volume":"222","author":"Alli","year":"2020","journal-title":"J Infect Dis"},{"key":"10.1136\/ijgc-2021-003327_bb0160","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1086\/383479","article-title":"Relationship between smoking and human papillomavirus infections in HIV-infected and -uninfected women","volume":"189","author":"Minkoff","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1136\/ijgc-2021-003327_bb0165","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.1002\/ijc.32693","article-title":"Epidemiological evidence that common HPV types may be common because of their ability to evade immune surveillance: results from the Women\u2019s Interagency HIV study","volume":"146","author":"Castle","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2021-003327_bb0170","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.29913","article-title":"Immunodeficiency and the risk of cervical intraepithelial neoplasia 2\/3 and cervical cancer: a nested case-control study in the Swiss HIV cohort study","volume":"138","author":"Clifford","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1136\/ijgc-2021-003327_bb0175","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1405044","article-title":"A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women","volume":"372","author":"Joura","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1136\/ijgc-2021-003327_bb0180","doi-asserted-by":"crossref","first-page":"5753","DOI":"10.1016\/j.vaccine.2017.05.069","article-title":"Human papillomavirus vaccines: WHO position paper, May 2017-Recommendations","volume":"35","author":"World Health Organization","year":"2017","journal-title":"Vaccine"},{"key":"10.1136\/ijgc-2021-003327_bb0185","doi-asserted-by":"crossref","first-page":"5745","DOI":"10.1016\/j.vaccine.2013.09.032","article-title":"Safety and immunogenicity of the HPV-16\/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study","volume":"31","author":"Denny","year":"2013","journal-title":"Vaccine"},{"key":"10.1136\/ijgc-2021-003327_bb0190","article-title":"Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males","volume":"2019","author":"Bergman","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1136\/ijgc-2021-003327_bb0195","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(19)30298-3","article-title":"Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis","volume":"394","author":"Drolet","year":"2019","journal-title":"Lancet"},{"key":"10.1136\/ijgc-2021-003327_bb0200","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pvr.2017.06.002","article-title":"HPV vaccination of immunocompromised hosts","volume":"4","author":"Garland","year":"2017","journal-title":"Papillomavirus Res"}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24010004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24010004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ijgc-2021-003327","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T22:40:15Z","timestamp":1753224015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24010004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S1048891X24010004"],"URL":"https:\/\/doi.org\/10.1136\/ijgc-2021-003327","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genotype-specific high-risk human papillomavirus infections and risk factors for cervical dysplasia in women with human immunodeficiency virus in Germany: results from a single-center cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ijgc-2021-003327","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 IGCS and ESGO 2022. No commercial re-use. See rights and permissions. Published by BMJ.","name":"copyright","label":"Copyright"}]}}